Agilent Technologies (A) Posts Quarterly Earnings Results, Beats Expectations By $0.07 EPS
Agilent Technologies (NYSE:A) released its quarterly earnings results on Monday. The medical research company reported $0.81 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.74 by $0.07, Bloomberg Earnings reports. The business had revenue of $1.29 billion during the quarter, compared to analyst estimates of $1.26 billion. Agilent Technologies had a net margin of 6.20% and a return on equity of 18.61%. The business’s revenue was up 8.8% on a year-over-year basis. During the same period last year, the business earned $0.67 EPS.
A stock traded down $2.38 during mid-day trading on Monday, hitting $62.61. 3,390,980 shares of the company were exchanged, compared to its average volume of 2,569,233. The firm has a market cap of $20.72 billion, a P/E ratio of 26.53, a P/E/G ratio of 2.03 and a beta of 1.35. The company has a debt-to-equity ratio of 0.39, a current ratio of 3.62 and a quick ratio of 3.00. Agilent Technologies has a twelve month low of $60.42 and a twelve month high of $75.00.
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 23rd. Shareholders of record on Monday, December 31st will be issued a dividend of $0.164 per share. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.15. This represents a $0.66 annualized dividend and a yield of 1.05%. The ex-dividend date is Friday, December 28th. Agilent Technologies’s dividend payout ratio (DPR) is currently 25.42%.
A number of equities research analysts recently weighed in on A shares. Goldman Sachs Group raised shares of Agilent Technologies from a “buy” rating to a “conviction-buy” rating in a report on Monday, September 17th. ValuEngine lowered shares of Agilent Technologies from a “buy” rating to a “hold” rating in a report on Tuesday, October 23rd. Morgan Stanley raised their price target on shares of Agilent Technologies from $84.00 to $86.00 and gave the company an “overweight” rating in a report on Wednesday, October 10th. Deutsche Bank raised their price target on shares of Agilent Technologies from $77.00 to $80.00 and gave the company a “buy” rating in a report on Wednesday, August 15th. Finally, Cleveland Research lowered shares of Agilent Technologies from a “buy” rating to a “neutral” rating in a report on Monday, November 12th. Two research analysts have rated the stock with a hold rating and nine have given a buy rating to the company. Agilent Technologies currently has an average rating of “Buy” and an average price target of $77.44.
Agilent Technologies Company Profile
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. It operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; microfluidics based automated electrophoresis products; cell analysis plate based assays; laboratory software and informatics systems; laboratory automation; dissolution testing; vacuum pumps; and measurement technologies.
Further Reading: Swap
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.